Adult stroke and perinatal brain damage: Like grandparent, like grandchild?

Neuropediatrics

Volumn 33, Issue 6, 2002, Pages 281-287

  Leviton, A ^a   Dammann, O ^a,b   O'Shea, T M ^c   Paneth, N ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Brain; Infant; Inflammation; Newborn; Stroke

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; PADGEM PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

BRAIN CELL; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CYTOKINE RELEASE; ENDOTHELIUM CELL; GESTATIONAL AGE; HUMAN; INFLAMMATION; LEUKOCYTE; MEASUREMENT; NONHUMAN; PATHOGENESIS; PERINATAL MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; STROKE; THROMBOCYTE; WHITE MATTER;

ADULT; AGED; ANIMALS; BRAIN DAMAGE, CHRONIC; CEREBRAL INFARCTION; CEREBRAL PALSY; ENDOTHELIUM, VASCULAR; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INFLAMMATION MEDIATORS; LEUKOCYTES; RISK FACTORS;

EID: 0036993523     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-37089     Document Type: Review

References (64)

1. Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997; 34: 366-370
2. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468-469
3. Anwaar I, Gottsater A, Lindgarde F, Mattiasson I. Increasing plasma neopterin and persistent plasma endothelin during follow-up after acute cerebral ischemia. Angiology 1999; 50: 1-8
4. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19: 819-834
5. Barone FC, Ohlstein EH, Hunter AJ, Campbell CA, Hadingham SH, Parsons AA et al. Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat. J Cardiovasc Pharmacol 2000; 36: S357-S361
6. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995; 37: 800-805
7. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P. A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998; 29: 2129-2135
8. Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997; 28: 1961-1965
9. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 1999; 163: 3963-3968
10. Chen J, Simon R. Ischemic tolerance in the brain. Neurology 1997; 48: 306-311
11. Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res 1997; 46: 382-391
12. Dammann O, Durum S, Leviton A. Do white cells matter in white matter damage? Trends Neurosci 2001; 24: 320-324
13. Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter LJ et al. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001; 13: 234-239
14. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-229
15. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000; 10: 95-112
16. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1-8
17. Duggan PJ, Maalouf EF, Watts TL, Sullivan MH, Counsell SJ, Allsop J et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 358: 1699-1700
18. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002; 33: 31-38
19. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996; 27: 1734-1738
20. Els T, Bruckmann J, Rohn G, Daffertshofer M, Monting JS, Ernestus RI et al. Spermidine: A predictor for neurological outcome and infarct size in focal cerebral ischemia? Stroke 2001; 32: 43-46
21. Estrada V, Tellez MJ, Moya J, Fernandez-Durango R, Egido J, Fernandez Cruz AF. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 1994; 7: 1085-1089
22. Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999; 30: 1647-1650
23. Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995; 26: 1361-1364
24. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994; 122: 135-139
25. Fassbender K, Schmidt R, Schreiner A, Fatar M, Muhlhauser F, Daffertshofer M et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 1997; 148: 101-105
26. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 1999; 19: 1004-1009
27. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77: 1081-1085
28. Frenette PS, Wagner DD. Adhesion molecules - Part 1. N Engl J Med 1996; 334: 1526-1529
29. Frijns CJ, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997; 28: 2214-2218
30. Gregersen R, Lambertsen K, Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000; 20: 53-65
31. Grether JK, Nelson KB, Dambrosia JM, Phillips TM. Interferons and cerebral palsy. J Pediatr 1999; 134: 324-332
32. Haapaniemi E, Tatlisumak T, Hamel K, Soinne L, Lanni C, Opgenorth TJ et al. Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischemic stroke. Stroke 2000; 31: 720-725
33. Hamann GF, Isenberg E, Strittmatter M, Moili R, Schimrigk K. Bigendothelin in acute ischemic stroke. J Stroke Cerebrovasc Dis 1993; 3: 256-260
34. Hamann GF, Isenberg E, Strittmatter M, Stoll M, Keshevar T, Moili R et al. Big endothelin in spontaneous intracerebral hemorrhage. Eur Neurol 1994; 34: 99-102
35. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100 B and glial fibrillary acidic protein. Stroke 2000; 31: 2670-2677
36. Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 2000; 50: 184-195
37. Kaneko M, Sasahara M, Takayama S, Handa J, Hazama F. Expression of platelet-derived growth factor after transient forebrain ischemia in the gerbil hippocampus. Acta Neuropathol (Berl) 1998; 95: 471-478
38. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996; 27: 1553-1557
39. Kim JS, Chopp M, Chen H, Levine SR, Carey JL, Welch KM. Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 1995; 128: 45-50
40. Kostulas N, Pelidou SH, Kivisakk P, Kostulas V, Link H. Increased IL-1 beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 1999; 30: 2174-2179
41. Kostulas N, Kivisakk P, Huang Y, Matusevicius D, Kostulas V, Link H. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 1998; 29: 462-466
42. Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S. Endothelial markers and adhesion molecules in acute ischemic stroke - sequential change and differences in stroke subtype. Atherosclerosis 2002; 161: 161-168
43. Kuban KC. White-matter disease of prematurity, periventricular leukomalacia, and ischemic lesions. Dev Med Child Neurol 1998; 40: 571-573
44. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas 1, Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 1997; 28: 1951-1955
45. Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr 2002; 91: 9-13
46. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2000; 1497: 1-10
47. Minagawa K, Tsuji Y, Ueda H, Koyama K, Tanizawa K, Okamura H et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 2002: 17: 164-170
48. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956-1960
49. Munoz A, Gange SJ. Methodological issues for biomarkers and intermediate outcomes in cohort studies. Epidemiol Rev 1998; 20: 29-42
50. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-675
51. Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001; 7: 222-227
52. Pelidou SH, Kostulas N, Matusevicius D, Kivisakk P, Kostulas V, Link H. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Eur J Neurol 1999; 6: 437-442
53. Shyu KG, Chang H, Lin CC. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol 1997; 244: 90-93
54. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 2000; 31: 1863-1870
55. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995; 26: 1393-1398
56. Temesgen Z, Girard SE. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease. Expert Opin Pharmacother 2001; 2: 765-772
57. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83: 113-118
58. Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 2000; 28: 1854-1860
59. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31: 2325-2329
60. Wu G, Li F, Li P, Ruan C. Detection of plasma alpha-granule membrane protein GMP-140 using radiolabeled monoclonal antibodies in thrombotic diseases. Haemostasis 1993; 23: 121-128
61. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-1195
62. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174: 1433-1440
63. Zhao B, Schwartz JP. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J Neurosci Res 1998; 52: 7-16
64. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 1992; 23: 1014-1016